Borellini Flavia 4
4 · Viracta Therapeutics, Inc. · Filed Jun 24, 2024
Insider Transaction Report
Form 4
Borellini Flavia
Director
Transactions
- Award
Stock Option (Right to Buy)
2024-06-20+50,000→ 50,000 totalExercise: $0.57Exp: 2034-06-20→ Common Stock (50,000 underlying)
Footnotes (1)
- [F1]1/12th of the shares subject to the option shall vest each month following the date of grant, or if earlier 100% of the shares subject to the option shall vest on the date of the Issuer's next annual stockholder meeting, in each case subject to the reporting person remaining a Service Provider (as defined in the 2021 Equity Incentive Plan) through the applicable vesting date.